Clinical Evidence and Safety Profile of Emicizumab for the Management of Children with Hemophilia A

Clinical Evidence and Safety Profile of Emicizumab for the Management of Children with Hemophilia A

Sandra Le Quellec1,2 1Unité d’hémostase Clinique – Hôpital Cardiologique Louis Pradel – Hospices Civils de Lyon, Lyon, France; 2Service d’hématologie biologique, Groupement Hospitalier Est – Hospices Civils...

Full description

Bibliographic Details
Main Author: Le Quellec S
Format: Article
Language:English
Published: Dove Medical Press 2020-02-01
Series:Drug Design, Development and Therapy
Subjects:
emicizumab
hemophilia a
inhibitors
factor viii
prophylaxis
subcutaneous
Online Access:https://www.dovepress.com/clinical-evidence-and-safety-profile-of-emicizumab-for-the-management--peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/clinical-evidence-and-safety-profile-of-emicizumab-for-the-management--peer-reviewed-article-DDDT

Similar Items